Mirum Pharmaceuticals Files 8-K Report
Ticker: MIRM · Form: 8-K · Filed: Apr 27, 2026 · CIK: 0001759425
| Field | Detail |
|---|---|
| Company | Mirum Pharmaceuticals, Inc. (MIRM) |
| Form Type | 8-K |
| Filed Date | Apr 27, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Mirum Pharma filed an 8-K on 4/27/26, no major news but keeping the market updated.
AI Summary
On April 27, 2026, Mirum Pharmaceuticals, Inc. filed an 8-K report detailing other events. The filing does not contain specific financial figures or new material agreements, but serves as a notification of events relevant to the company's operations.
Why It Matters
This filing indicates that Mirum Pharmaceuticals is making a regulatory disclosure, which could be related to ongoing business activities or strategic developments.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose any immediate financial risks or significant changes.
Key Players & Entities
- Mirum Pharmaceuticals, Inc. (company) — Filer of the 8-K report
- 0001759425 (company) — CIK number for Mirum Pharmaceuticals, Inc.
- 2026-04-27 (date) — Filing date and period of report
FAQ
What type of event is disclosed in this 8-K filing?
This 8-K filing is for 'Other Events' as per Item 8.01.
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-27 at 08:07:58.
What is the CIK number for Mirum Pharmaceuticals, Inc.?
The CIK number for Mirum Pharmaceuticals, Inc. is 0001759425.
What is the business address of Mirum Pharmaceuticals, Inc.?
The business address is 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404.
What is the SIC code listed for Mirum Pharmaceuticals, Inc.?
The SIC code listed is 2834 for Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 27, 2026 regarding Mirum Pharmaceuticals, Inc. (MIRM).